Medications Data Interoperability Project

The Medications Data Interoperability Project (MDIP) was a Horizon funded project conducted by Dynaccurate and Pillcheck to create a large scale database of linked medications sourced from the EU, Canada, UK and USA that flagged medications associated with potential pharmacogenomic impacts.  Pharmacogenomics refers to the branch of genetics which studies the way in which an individual's genetic attributes may affect their personal response to therapeutic drugs. This is also known as a gene/drug reaction, and it can be an adverse effect for a patient, similar to drug/drug and food/drug reactions.

 

Our project began in January 2025 and concluded in September 2025. We gathered close to one million medications references from across the target countries and now display those which have a pharmacogenomic flag in a searchable database. We use AI technologies to achieve Semantic Interoperability between different medications datasets published or provided by public authorities, such as regulators, terminology severs, medicines agencies or pharma industry bodies.

 

For each individual source, we wrote the metadata to the Blockchain as a demonstration of how to ensure provenance. An important part of this project is demonstrating to stakeholders how it is possible to aggregate important, publicly available sources of information. This is necessary to achieve lower spending and wider applications in the field of health, and in this case, the management of medications, stock control, adverse reaction tracking as well supplies and budgetary control. It is also helps fight against counterfeit medications.

 

To enhance public awareness we also used an off-the-shelf AI Avatar called Maddi – the Medications Data Digital Advisor – to give project updates.  Visit the Project Blog to see more of Maddi and more about what we did!

​

​